Kaposi sarcoma-associated herpesvirus human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma

被引:16
作者
Biberfeld, P [1 ]
Ensoli, B [1 ]
Stürzl, M [1 ]
Schulz, TF [1 ]
机构
[1] Karolinska Hosp & Inst, Inst Oncol Pathol, Immunopathol Lab, Stockholm, Sweden
关键词
D O I
10.1097/00001432-199804000-00002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Epidemiological studies have strengthened the case for Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 being the long-sought Kaposi sarcoma agent, but have also pointed to a role for other co-factors. Like other tumour viruses, Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 establishes a latent (persistent) infection in Kaposi sarcoma-spindle (tumorous) cells, but can also undergo lytic replication in these and other cell types. Several latent and lytic viral genes may play a role in the pathogenesis of Kaposi's sarcoma. Although Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 contains at least two genes with transforming properties, it has not yet been shown to be oncogenic in animals. This, and other studies on inflammatory/angiogenic cellular and viral cytokines as well as HIV-Tat, emphasizes the multifactorial complexity of the pathogenesis of Kaposi's sarcoma. (C) 1998 Rapid Science Ltd.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 112 条
  • [1] Ablashi D. V., 1997, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V14, pA23
  • [2] Kaposis sarcoma as manifestation of immunosuppression in organ transplant recipients
    Aebischer, MC
    Zala, LB
    Braathen, LR
    [J]. DERMATOLOGY, 1997, 195 (01) : 91 - 92
  • [3] The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells
    Albini, A
    Soldi, R
    Giunciuglio, D
    Giraudo, E
    Benelli, R
    Primo, L
    Noonan, D
    Salio, M
    Camussi, G
    Rockl, W
    Bussolino, F
    [J]. NATURE MEDICINE, 1996, 2 (12) : 1371 - 1375
  • [4] Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma
    Andre, S
    Schatz, O
    Bogner, JR
    Zeichhardt, H
    StofflerMeilicke, M
    Jahn, HU
    Ullrich, R
    Sonntag, AK
    Kehm, R
    Haas, J
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (02): : 145 - 152
  • [5] ARIYOSHI K, 1998, IN PRESS J HUMAN VIR
  • [6] Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation
    Arvanitakis, L
    GerasRaaka, E
    Varma, A
    Gershengorn, MC
    Cesarman, E
    [J]. NATURE, 1997, 385 (6614) : 347 - 350
  • [7] G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
    Bais, C
    Santomasso, B
    Coso, O
    Arvanitakis, L
    Raaka, EG
    Gutkind, JS
    Asch, AS
    Cesarman, E
    Gerhengorn, MC
    Mesri, EA
    [J]. NATURE, 1998, 391 (6662) : 86 - 89
  • [8] BARILLARI G, 1997, J ACQ IMMUN DEF SYND, V114, pA33
  • [9] RISK OF KAPOSIS-SARCOMA AND SEXUAL PRACTICES ASSOCIATED WITH FECAL CONTACT IN HOMOSEXUAL OR BISEXUAL MEN WITH AIDS
    BERAL, V
    BULL, D
    DARBY, S
    WELLER, I
    CARNE, C
    BEECHAM, M
    JAFFE, H
    [J]. LANCET, 1992, 339 (8794) : 632 - 635
  • [10] Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
    Bertin, J
    Armstrong, RC
    Ottilie, S
    Martin, DA
    Wang, Y
    Banks, S
    Wang, GH
    Senkevich, TG
    Alnemri, ES
    Moss, B
    Lenardo, MJ
    Tomaselli, KJ
    Cohen, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) : 1172 - 1176